Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2024. The report specifically details a transaction in the company's own shares executed on August 21, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity:
- Shares Purchased: 424,232 ordinary shares
- Price Range: Lowest 372.20 pence; Highest 374.40 pence
- Volume Weighted Average Price: 373.0982 pence
- Post-Transaction Share Capital: 9,126,880,520 ordinary shares
Material Changes
The primary material change is the reduction of the company's registered share capital following the cancellation of the 424,232 shares purchased. No other material changes to financial position or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It serves as a regulatory disclosure of a completed share transaction in compliance with the Market Abuse Regulation.
Investor Verification Checklist
- Verify the total number of shares repurchased to date under the August 1, 2024 Buyback Programme.
- Confirm the updated total share capital of 9,126,880,520 shares for disclosure threshold calculations.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction data.